Verici DX (VRCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 May 2021 04:35 PM
RNS
Price Monitoring Extension
19 May 2021 03:14 PM
RNS
Result of AGM
05 May 2021 07:00 AM
RNS
Notice of Change of AGM Venue
29 Apr 2021 07:00 AM
RNS
Lease signed for laboratory
14 Apr 2021 07:01 AM
RNS
MTA secured to assess CTOT-19 samples
14 Apr 2021 07:00 AM
RNS
Final Results
13 Apr 2021 02:06 PM
RNS
Second Price Monitoring Extn
13 Apr 2021 02:01 PM
RNS
Price Monitoring Extension
13 Apr 2021 11:05 AM
RNS
Second Price Monitoring Extn
13 Apr 2021 11:00 AM
RNS
Price Monitoring Extension
17 Mar 2021 07:00 AM
RNS
Notice of Results
02 Mar 2021 07:00 AM
RNS
First clinical trial sites initiated in US
09 Feb 2021 07:00 AM
RNS
Capital Markets Day for Kidney Health
08 Feb 2021 07:00 AM
RNS
Accelerated CLIA approval strategy
05 Feb 2021 04:41 PM
RNS
Second Price Monitoring Extn
05 Feb 2021 04:36 PM
RNS
Price Monitoring Extension
18 Jan 2021 02:06 PM
RNS
Second Price Monitoring Extn
18 Jan 2021 02:00 PM
RNS
Price Monitoring Extension
18 Jan 2021 11:05 AM
RNS
Second Price Monitoring Extn
18 Jan 2021 11:01 AM
RNS
Price Monitoring Extension
15 Jan 2021 04:40 PM
RNS
Second Price Monitoring Extn
15 Jan 2021 04:35 PM
RNS
Price Monitoring Extension
11 Jan 2021 07:00 AM
RNS
Additional patent licence with Mount Sinai
23 Dec 2020 07:00 AM
RNS
Appointment of Senior Director
12 Nov 2020 04:34 PM
RNS
Holding(s) in Company
12 Nov 2020 04:34 PM
RNS
Holding(s) in Company
05 Nov 2020 05:03 PM
RNS
Holding(s) in Company
03 Nov 2020 07:00 AM
RNS
AIM Admission & First Day of Dealings

Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.

Verici Dx share price is listed in London under the ticker VRCI.

UK 100

Latest directors dealings